William Blair Has Bullish Estimate for PTCT Q1 Earnings
PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) – Analysts at William Blair lifted their Q1 2025 earnings per share (EPS) estimates for PTC Therapeutics in a note issued to investors on Wednesday, May 7th. William Blair analyst S. Corwin now expects that the biopharmaceutical company will earn $10.04 per share for the quarter, up from […]
